Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer, Breast|Triple Negative Breast Cancer
Interventions: DRUG: Atezolizumab|DRUG: Pegylated liposomal doxorubicin|DRUG: Cyclophosphamide|OTHER: Placebo
Sponsor: Oslo University Hospital
Collaborators: Hoffmann-La Roche|Norwegian Cancer Society|St. Olavs Hospital|Helse Stavanger HF|Rigshospitalet, Denmark|Vejle Hospital|NanoString Technologies, Inc.|Technical University of Denmark|Karolinska Institutet